Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years — United States, March 1, 2020–June 28, 2021
Catherine Barrett, Alain K. Koyama, Pablo Álvarez, Wilson Chow, Elizabeth A. Lundeen, Cria G. Perrine, Meda E. Pavkov, Deborah B. Rolka, Jennifer L. Wiltz, Lara Bull–Otterson, Simone C. Gray, Tegan K. Boehmer, Adi V. Gundlapalli, David A. Siegel, Lyudmyla Kompaniyets, Alyson B. Goodman, Barbara E. Mahon, Robert V. Tauxe, Karen Remley, Sharon Saydah
Abstract
in addition to chronic disease prevention and management. The mechanism of how SARS-CoV-2 might lead to incident diabetes is likely complex and could differ by type 1 and type 2 diabetes. Monitoring for long-term consequences, including signs of new diabetes, following SARS-CoV-2 infection is important in this age group.
Topics & Concepts
MedicineDiabetes mellitusIncidence (geometry)Type 2 diabetesPandemicDiabetic ketoacidosisType 1 diabetesPediatricsHazard ratioYoung adultCoronavirus disease 2019 (COVID-19)Retrospective cohort studyInternal medicineDiseaseInfectious disease (medical specialty)EndocrinologyConfidence intervalOpticsPhysicsDiabetes and associated disordersDiabetes Management and ResearchCOVID-19 Clinical Research Studies